Scripps Research Logo

The Mosier Laboratory


  1. Lederman, M.M., A. Penn-Nicholson, M. Cho, and D. Mosier. 2006. Biology of CCR5 and its role in HIV infection and treatment. Jama 296:815-826.
  2. Pastore, C., R. Nedellec, A. Ramos, S. Pontow, L. Ratner, and D.E. Mosier. 2006. Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations. J Virol 80:750-758.
  3. Blish, C.A., R. Nedellec, K. Mandaliya, D.E. Mosier, and J. Overbaugh. 2007. HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry. Aids 21:693-702.
  4. Kiselyeva, Y., R. Nedellec, A. Ramos, C. Pastore, L.B. Margolis, and D.E. Mosier. 2007. Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutations. J Virol 81:3657-3661.
  5. Mosier, D.E. 2007. Changes in HIV-1 Tropism: Clinical and Prognostic Consequences. European journal of medical research 12:371-374.
  6. Pastore, C., R. Nedellec, A. Ramos, O. Hartley, J.L. Miamidian, J.D. Reeves, and D.E. Mosier. 2007. Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching. J Virol 81:8165-8179.
  7. Strizki, J., and D. Mosier. 2007. Inhibitors that target gp120 interactions with coreceptor. In Entry Inhibitors in HIV Therapy. J.D. Reeves, and C.A. Derdeyn, editors. Birkhauser, Basel, Switzerland. 63-78.
  8. Coetzer, M., R. Nedellec, J.R. Salkowitz, S. McLaughlin, Y. Liu, L. Heath, J.I. Mullins, and D.E. Mosier. 2008. Evolution of CCR5 use before and during coreceptor switching. J Virol 82:11758-11766.
  9. Grant, R.M., D. Hamer, T. Hope, R. Johnston, J. Lange, M.M. Lederman, J. Lieberman, C.J. Miller, J.P. Moore, D.E. Mosier, D.D. Richman, R.T. Schooley, M.S. Springer, R.S. Veazey, and M.A. Wainberg. 2008. Whither or wither microbicides? Science 321:532-534.
  10. Gaertner, H., F. Cerini, J.M. Escola, G. Kuenzi, A. Melotti, R. Offord, I. Rossitto-Borlat, R. Nedellec, J. Salkowitz, G. Gorochov, D. Mosier, and O. Hartley. 2008. Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide. Proc Natl Acad Sci U S A 105:17706-17711.